260 related articles for article (PubMed ID: 11178967)
1. Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100.
Kim HS; Lee TB; Choi CH
Biochem Biophys Res Commun; 2001 Feb; 281(1):109-14. PubMed ID: 11178967
[TBL] [Abstract][Full Text] [Related]
2. Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines.
Choi CH; Xu H; Bark H; Lee TB; Yun J; Kang SI; Oh YK
Leuk Res; 2007 Sep; 31(9):1267-76. PubMed ID: 17218010
[TBL] [Abstract][Full Text] [Related]
3. Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells.
Lenehan PF; Gutiérrez PL; Wagner JL; Milak N; Fisher GR; Ross DD
Cancer Chemother Pharmacol; 1995; 35(5):377-86. PubMed ID: 7850918
[TBL] [Abstract][Full Text] [Related]
4. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
Kim HS; Min YD; Choi CH
Biochem Biophys Res Commun; 2001 Apr; 283(1):64-71. PubMed ID: 11322768
[TBL] [Abstract][Full Text] [Related]
5. Anti-oxidant adaptation in the AML cells supersensitive to hydrogen peroxide.
Oh YK; Lee TB; Choi CH
Biochem Biophys Res Commun; 2004 Jun; 319(1):41-5. PubMed ID: 15158439
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species-specific mechanisms of drug resistance in paraquat-resistant acute myelogenous leukemia sublines.
Choi CH; Kim HS; Kweon OS; Lee TB; You HJ; Rha HS; Jeong JH; Lim DY; Min YD; Kim MS; Chung MH
Mol Cells; 2000 Feb; 10(1):38-46. PubMed ID: 10774745
[TBL] [Abstract][Full Text] [Related]
7. Histone H4 deacetylation down-regulates catalase gene expression in doxorubicin-resistant AML subline.
Lee TB; Moon YS; Choi CH
Cell Biol Toxicol; 2012 Feb; 28(1):11-8. PubMed ID: 21968610
[TBL] [Abstract][Full Text] [Related]
8. Elevated reactive oxygen species but not glutathione regulate mercury resistance to AML-2/DX100 cells.
Choi CH; Bark H; Chung JM; Park EK; Kim SH
Immunopharmacol Immunotoxicol; 2006; 28(3):545-55. PubMed ID: 16997801
[TBL] [Abstract][Full Text] [Related]
9. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng.
Choi CH; Kang G; Min YD
Planta Med; 2003 Mar; 69(3):235-40. PubMed ID: 12677527
[TBL] [Abstract][Full Text] [Related]
10. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance.
Harbottle A; Daly AK; Atherton K; Campbell FC
Int J Cancer; 2001 Jun; 92(6):777-83. PubMed ID: 11351295
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
Zaja R; Caminada D; Loncar J; Fent K; Smital T
Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the antioxidant activities in dox-sensitive and -resistant Friend leukemia cells. Effect of doxorubicin.
Crescimanno M; D'Alessandro N; Armata MG; Toulmond S; Tapiero H
Anticancer Res; 1991; 11(2):901-3. PubMed ID: 2064348
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells.
Yu M; Shi Y; Wei X; Yang Y; Zang F; Niu R
Eur J Cancer Prev; 2009 Nov; 18(6):445-57. PubMed ID: 19609211
[TBL] [Abstract][Full Text] [Related]
14. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the oxidative stress response of Penicillium chrysogenum to menadione.
Emri T; Pócsi I; Szentirmai A
Free Radic Res; 1999 Feb; 30(2):125-32. PubMed ID: 10193580
[TBL] [Abstract][Full Text] [Related]
16. Effects of paraquat on anti-oxidant system in rats.
Ray S; Sengupta A; Ray A
Indian J Exp Biol; 2007 May; 45(5):432-8. PubMed ID: 17569284
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells.
Akman SA; Forrest G; Chu FF; Esworthy RS; Doroshow JH
Cancer Res; 1990 Mar; 50(5):1397-402. PubMed ID: 2406012
[TBL] [Abstract][Full Text] [Related]
18. Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P388/DOX resistant and P388 parental cell lines.
Liu QY; Tan BK
Life Sci; 2000; 67(10):1207-18. PubMed ID: 10954054
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression.
Kweon SH; Song JH; Kim TS
Biochem Biophys Res Commun; 2010 Apr; 395(1):104-10. PubMed ID: 20350534
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of enzymes of the glutathione antioxidant system by treatment of cultured human keratinocytes with peroxides.
Vessey DA; Lee KH
J Invest Dermatol; 1993 Jun; 100(6):829-33. PubMed ID: 8496623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
